JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다. 전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.
1Department of Pediatric Oncology/Hematology,VU University Medical Center, 2Department of Hematology,VU University Medical Center, 3Department of Medical Oncology,VU University Medical Center, 4Department of Clinical Genetics,VU University Medical Center, 5Division of General and Transplant Surgery, Azienda Ospedaliera Universitaria Pisana,Universita’ di Pisa, 6Amsterdam Immunology and Rheumatology Center,VU University Medical Center, 7Princess Máxima Center for Pediatric Oncology, 8Cancer Pharmacology Lab, AIRC Start-Up Unit,University of Pisa, 9Institute of Nanoscience and Nanotechnology,CNR-Nano
Chapters
- 00:05Title
- 01:09Characterization of Drug Resistance Profiles through Cytotoxicity Assays
- 05:01RNA Isolation and Library Preparation for RNA-sequencing
- 05:55Validation of the Results by RT-PCR and qRT-PCR Assays
- 07:21Results: Detection of Differential Splicing Events in Chemotherapy-resistant Cell Lines Compared to Parental Wild-type by Using RNA-sequencing
- 09:07Conclusion
Aqui nós descrevemos um protocolo teve como objetivo investigar o impacto do splicing aberrante na resistência aos medicamentos em tumores sólidos e doenças malignas hematológicas. Para este objetivo, foram analisados os perfis transcriptomic de modelos parentais e resistentes in vitro através de RNA-seq e estabeleceu um método baseado qRT-PCR para validar genes candidatos.
